| Year |
Citation |
Score |
| 2005 |
Neumann T, Hagmann I, Lohrengel S, Heil ML, Derdeyn CA, Kräusslich HG, Dittmar MT. T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells. Virology. 333: 251-62. PMID 15721359 DOI: 10.1016/j.virol.2004.12.035 |
0.316 |
|
| 2004 |
Heil ML, Decker JM, Sfakianos JN, Shaw GM, Hunter E, Derdeyn CA. Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site. Journal of Virology. 78: 7582-9. PMID 15220433 DOI: 10.1128/Jvi.78.14.7582-7589.2004 |
0.306 |
|
| 2004 |
Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, Heil ML, Kasolo F, Musonda R, Hahn BH, Shaw GM, Korber BT, Allen S, Hunter E. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science (New York, N.Y.). 303: 2019-22. PMID 15044802 DOI: 10.1126/Science.1093137 |
0.325 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2010 |
Chung DH, Jonsson CB, Maddox C, McKellip SN, Moore BP, Heil M, White EL, Ananthan S, Li Q, Feng S, Rasmussen L. HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity. Molecules (Basel, Switzerland). 15: 1690-704. PMID 20336008 DOI: 10.3390/Molecules15031690 |
0.279 |
|
| 2017 |
Pagano N, Teriete P, Mattmann ME, Yang L, Snyder BA, Cai Z, Heil ML, Cosford NDP. An integrated chemical biology approach reveals the mechanism of action of HIV replication inhibitors. Bioorganic & Medicinal Chemistry. PMID 28442262 DOI: 10.1016/j.bmc.2017.03.061 |
0.252 |
|
| 2007 |
Jones J, Rodgers J, Heil M, May J, White L, Maddry JA, Fletcher TM, Shaw GM, Hartman JL, Kutsch O. High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds. Assay and Drug Development Technologies. 5: 181-89. PMID 17477827 DOI: 10.1089/adt.2006.040 |
0.245 |
|
| 2006 |
Ochsenbauer-Jambor C, Jones J, Heil M, Zammit KP, Kutsch O. T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication. Biotechniques. 40: 91-100. PMID 16454046 DOI: 10.2144/000112072 |
0.235 |
|
| 2023 |
Testoni B, Scholtès C, Plissonnier ML, Paturel A, Berby F, Facchetti F, Villeret F, Degasperi E, Scott B, Hamilton A, Heil M, Lampertico P, Levrero M, Zoulim F. Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B. Gut. PMID 37879886 DOI: 10.1136/gutjnl-2023-330644 |
0.205 |
|
| 2017 |
Stelzl E, Haas B, Bauer B, Zhang S, Fiss EH, Hillman G, Hamilton AT, Mehta R, Heil ML, Marins EG, Santner BI, Kessler HH. First identification of a recombinant form of hepatitis C virus in Austrian patients by full-genome next generation sequencing. Plos One. 12: e0181273. PMID 28742818 DOI: 10.1371/journal.pone.0181273 |
0.166 |
|
| 2023 |
Testoni B, Roca Suarez AA, Battisti A, Plissonnier ML, Heil M, Fontanges T, Villeret F, Chouik Y, Levrero M, Gill U, Kennedy P, Zoulim F. Evaluation of the HBV liver reservoir with fine needle aspirates. Jhep Reports : Innovation in Hepatology. 5: 100841. PMID 37675272 DOI: 10.1016/j.jhepr.2023.100841 |
0.142 |
|
| 2006 |
Kempf MC, Jones J, Heil ML, Kutsch O. A high-throughput drug screening system for HIV-1 transcription inhibitors. Journal of Biomolecular Screening. 11: 807-15. PMID 16831859 DOI: 10.1177/1087057106290292 |
0.139 |
|
| 2022 |
Scholtès C, Hamilton AT, Plissonnier ML, Charre C, Scott B, Wang L, Berby F, French J, Testoni B, Blair A, Subic M, Hoppler M, Lankenau A, Grubenmann A, Levrero M, ... Heil ML, et al. Performance of the cobas® HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 105150. PMID 35427860 DOI: 10.1016/j.jcv.2022.105150 |
0.128 |
|
| 2021 |
Mellors JW, Guo S, Naqvi A, Brandt LD, Su L, Sun Z, Joseph KW, Demirov D, Halvas EK, Butcher D, Scott B, Hamilton A, Heil M, Karim B, Wu X, et al. Insertional activation of and by HIV-1 proviruses in T cell lymphomas. Science Advances. 7: eabi8795. PMID 34644108 DOI: 10.1126/sciadv.abi8795 |
0.109 |
|
| 2010 |
Heath L, Conway S, Jones L, Semrau K, Nakamura K, Walter J, Decker WD, Hong J, Chen T, Heil M, Sinkala M, Kankasa C, Thea DM, Kuhn L, Mullins JI, et al. Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. Plos One. 5: e10213. PMID 20422033 DOI: 10.1371/Journal.Pone.0010213 |
0.092 |
|
| 2005 |
Zhang W, Heil M, Kuhn RJ, Baker TS. Heparin binding sites on Ross River virus revealed by electron cryo-microscopy. Virology. 332: 511-8. PMID 15680416 DOI: 10.1016/J.Virol.2004.11.043 |
0.091 |
|
| 2023 |
Villeret F, Lebossé F, Radenne S, Samuel D, Roche B, Mabrut JY, Leroy V, Pageaux GP, Anty R, Thevenon S, Ahmed SS, Hamilton A, Heil M, Scholtès C, Levrero M, et al. Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis. Jhep Reports : Innovation in Hepatology. 5: 100728. PMID 37122357 DOI: 10.1016/j.jhepr.2023.100728 |
0.086 |
|
| 2012 |
Pagano N, Heil ML, Cosford ND. Automated Multistep Continuous Flow Synthesis of 2-(1H-Indol-3-yl)thiazole Derivatives. Synthesis. 44: 2537-2546. PMID 24634547 DOI: 10.1055/S-0031-1290953 |
0.057 |
|
| Hide low-probability matches. |